Viewing Study NCT01727934


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-02 @ 9:29 AM
Study NCT ID: NCT01727934
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 2012-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C
Sponsor: Santaris Pharma A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antisense View
None miR-122 antagonist View
None host factor View
None Chronic hepatitis C View
None Hepatitis C View